National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

altretamine
A synthetic cytotoxic s-triazine derivative similar in structure to alkylating agent triethylenemelamin with antineoplastic activity. Although the precise mechanism by which altretamine exerts its cytotoxic effect is unknown, N-demethylation of altretamine may produce reactive intermediates which covalently bind to DNA, resulting in DNA damage. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Hemel
Hexaloids
US brand names:Hexalen
hexamethylmelamine
Foreign brand names:Hexastat
Hexinawas
Abbreviations:HMM
HXM
Code names:ENT-50852
RB-1515
WR-95704
Chemical structure names:
  • 2,4,6-tris(dimethylamino)-s-triazine
  • N,N,N',N',N",N"-hexamethyl-1,3,5-triazine-2,4,6-triamine



Previous:alpha-Gal glycosphingolipids, alpha-galactosylceramide-pulsed autologous dendritic cells, alprazolam, alprostadil, Althose
Next:alum adjuvant, ALVAC(2) melanoma multi-antigen therapeutic vaccine, ALVAC-hB7.1, ALVAC-MART-1 vaccine, alvespimycin hydrochloride

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov